- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05530018
Developing and Feasibility Testing of a Brief Contact Intervention to Reduce Self-harm Repetition Through Co-design.
September 29, 2022 updated by: National Taiwan University Hospital
Suicide is a major public health issue.
Repeated self-harm may lead to potential future suicide deaths.
In addition, it may lead to substantial loss in medical costs.
Recently, smartphones have been widely used.
Researchers started to apply mobile health to support individuals with self-harm experiences and to combine brief contact interventions which require lower cost to reduce repeated self-harm.
However, the research evidence remains sparse.
Furthermore, self-harm behaviors might be influenced by different cultural contexts.
There is a need to conduct local studies in Taiwan.
The aim of this study is to establish a co-design team which includes service users and service providers, to collaboratively develop a text- and web-based brief contact intervention (BCI) to reduce repeated self-harm, and to evaluate the feasibility of the intervention.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Study objectives:
- To establish a co-design team and develop a brief contact intervention (BCI), including the content, frequency, settings, and outcome measures of the intervention.
- To evaluate the feasibility of BCI, including the feasibility of recruitment, required resources, the appropriateness of data collection, and the acceptability of the BCI.
Methods:
- In study 1, we will recruit 4-6 service users and 4-6 service providers respectively, and we will conduct focus groups to discuss the content of the BCI. We will conduct individual interviews with participants to explore their experiences and perspectives regarding their participation in the co-design team.
- In study 2, we will recruit 30 participants who have self-harm experiences to participate in the BCI. The BCI will be delivered through texts and web pages and will last around 5 months. The content of BCI will include caring messages, reminders of appointments, safety planning, volitional help sheet, and resources information. We will collect user engagement data and compare study outcomes (e.g., suicidal ideation and behaviors, brief symptom rating scale (BSRS), and mental well-being scale) before and after receiving the BCI. We will collect the participants' feedback regarding the BCI and evaluate the required resources to further revise the BCI.
Study Type
Interventional
Enrollment (Anticipated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shu-Sen Chang, MD, MSc, PhD
- Phone Number: +886 2 33668062
- Email: shusenchang@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Shu-Sen Chang, MD, MSc, PhD
- Phone Number: +886 2 33668062
- Email: shusenchang@ntu.edu.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 20 years or over
- Mentally and physically stable and able to participate in individual interviews and interventions
- Able to communicate in Mandarin and provide written informed consent
- Willing to be recorded during the interviews
- Received medical treatments or aftercare due to self-harm experiences, including self-harm ideations, self-harm behaviors, suicidal ideations, and suicidal attempts.
- Able to use the smartphone to access the internet
Exclusion Criteria:
- Mental and physical states are unstable (e.g., unconscious, severe psychiatric symptoms, strong suicidal ideations with specific suicide plans) to complete the interviews and interventions according to the health professionals.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BCI group
Participants will be asked to participate in a brief contact intervention and to evaluate its feasibility, including the feasibility of recruitment, intervention resources, the appropriateness of data collection, and the acceptance of the intervention.
|
The brief contact intervention (BCI) will send out text messages to the participants.
The text messages will include caring messages, reminders of appointments, and a link to a web page.
The web page is anticipated to include safety planning, volitional helpsheet, and resources information.
The text messages are anticipated to send out to the participants on a weekly base for 6 weeks in a row, and then change to monthly reminders.
The monthly reminders are anticipated to include caring messages, reminders of appointments, and invitations to encourage the participants to click the previous web links again.
The monthly reminders are anticipated to send out to the participants three times in a row.
In the final reminder, the participants will be told that this intervention is going to end.
In total, the participants will receive 9 texts within 5 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The acceptability of the intervention to participants
Time Frame: within 6 months of study completion
|
The investigators will conduct face-to-face qualitative interviews to understand the acceptability of the intervention amongst participants.
|
within 6 months of study completion
|
The feasibility of intervention to participants
Time Frame: within 6 months of study completion
|
The investigators will conduct face-to-face qualitative interviews to understand the feasibility of intervention amongst participants.
|
within 6 months of study completion
|
Participant recruitment
Time Frame: through study completion, an average of 1 year
|
Recruitment: the proportion of participants who are eligible and invited actually consent to participate.
|
through study completion, an average of 1 year
|
Participant retention rate
Time Frame: 1 month
|
The proportion of participants who can be reached by in-person or phone contact at the 1 month follow-up.
|
1 month
|
Participant retention rate
Time Frame: 3 month
|
The proportion of participants who can be reached by in-person or phone contact at the 3 month follow-up.
|
3 month
|
Participant retention rate
Time Frame: 6 month
|
The proportion of participants who can be reached by in-person or phone contact at the 6 month follow-up.
|
6 month
|
Number of repeated self-harm episodes (self-report)
Time Frame: 1 month
|
Number of repeated self-harm episodes per person at 1 month after intervention based on self-report.
|
1 month
|
Number of repeated self-harm episodes (self-report)
Time Frame: 3 month
|
Number of repeated self-harm episodes per person at 3 month after intervention based on self-report.
|
3 month
|
Number of repeated self-harm episodes (self-report)
Time Frame: 6 month
|
Number of repeated self-harm episodes per person at 6 month after intervention based on self-report.
|
6 month
|
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 1 month
|
Number of repeat self-harm episodes per person at 1 month after intervention recorded in the nationwide self-harm registry
|
1 month
|
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 3 month
|
Number of repeat self-harm episodes per person at 3 month after intervention recorded in the nationwide self-harm registry
|
3 month
|
Number of repeated self-harm episodes (nationwide self-harm registry)
Time Frame: 6 month
|
Number of repeat self-harm episodes per person at 6 month after intervention recorded in the nationwide self-harm registry
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-efficacy and stages of change questionnaire
Time Frame: 1 month, 3 months, 6 months
|
Access participants' self-efficacy and stages of change in relation to suicide ideation and attempt at 1/3/6 month.
|
1 month, 3 months, 6 months
|
Help-seeking behavior questionnaire
Time Frame: 1 month, 3 months, 6 months
|
Assess the help-seeking behaviors of participants at 1/3/6 month.
|
1 month, 3 months, 6 months
|
Brief Symptom Rating Scale (BSRS)
Time Frame: 1 month, 3 months, 6 months
|
Briefly evaluate the psychological distresses of participants at 1/3/6 month.
The total score ranges from 0 to 25. Categorized as "mild" with score 6-9, "moderate" with score 10-14, and "severe" with score more than 15.
|
1 month, 3 months, 6 months
|
The World Health Organisation- Five Well-Being Index (WHO-5)
Time Frame: 1 month, 3 months, 6 months
|
Measure the current mental wellbeing of participants at 1/3/6 month.
|
1 month, 3 months, 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Shu-Sen Chang, MD, MSc, PhD, National Taiwan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 19, 2022
Primary Completion (Anticipated)
July 1, 2024
Study Completion (Anticipated)
July 1, 2024
Study Registration Dates
First Submitted
August 31, 2022
First Submitted That Met QC Criteria
September 2, 2022
First Posted (Actual)
September 7, 2022
Study Record Updates
Last Update Posted (Actual)
September 30, 2022
Last Update Submitted That Met QC Criteria
September 29, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202206137RINA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide and Self-harm
-
Harvard UniversityNational Institute of Mental Health (NIMH); Massachusetts General HospitalUnknownSuicide, Attempted | Suicide and Self-harmUnited States
-
Region StockholmKarolinska InstitutetRecruitingSuicide and Self-harmSweden
-
National Taiwan University HospitalAcademia Sinica, TaiwanUnknownThe Effect of a Brief Psychological Intervention on Reducing Self-harm Repetition: Feasibility StudySuicide and Self-harmTaiwan
-
VA Eastern Colorado Health Care SystemCompleted
-
University of California, Los AngelesPatient-Centered Outcomes Research Institute; Brown University; Duke University; University of Utah and other collaboratorsRecruiting
-
Butler HospitalNational Institute of Mental Health (NIMH); Brown UniversityRecruitingSuicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harmUnited States
-
St. Luke's Health System, Boise, IdahoUniversity of Washington; American Foundation for Suicide Prevention; Idaho Crisis...RecruitingSuicide | Suicide and Self-harm | Suicide PreventionUnited States
-
Butler HospitalMichigan State UniversityActive, not recruitingSuicide and Self-harmUnited States
-
Winnipeg Regional Health AuthorityPrimary Supervisor: Dr. James Bolton MD FRCPCUnknownSuicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harm | Suicide GestureCanada
-
Stanford UniversityNot yet recruitingSuicide and Self-harmUnited States
Clinical Trials on Brief contact intervention
-
Shenzhen Kangning HospitalRecruiting
-
St. Joseph's Healthcare HamiltonRecruiting
-
St. Luke's Health System, Boise, IdahoPatient-Centered Outcomes Research Institute; University of Pennsylvania; Columbia... and other collaboratorsActive, not recruitingAdolescent | Depressive Disorder | Depression | Suicidal Ideation | Suicide, Attempted | Suicide | Mental Health | Loneliness | Social Support | Mental Disorder | Outpatients | Ambulatory Care | Continuity of Patient Care | Adult | Secondary Prevention | Emergency Service, Hospital | Mental Health Services | Patient Care Planning and other conditionsUnited States
-
State University of New York - Upstate Medical...RecruitingSuicidal IdeationUnited States
-
Boston Medical CenterNational Institute of Allergy and Infectious Diseases (NIAID); BU Clinical...Completed
-
The University of Texas Health Science Center at...59th Medical Wing; San Antonio Military Medical Center; Wright State UniversityCompletedPost-Traumatic Stress DisorderUnited States
-
i4HealthTerminated
-
Florida State UniversityNational Institute on Drug Abuse (NIDA)CompletedInsomnia | Substance Use Disorders | Posttraumatic Stress DisorderUnited States
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed